No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy-Reference-Cited by-同舟云学术

No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy

Published:2023-06-08 Issue:4 Volume:12 Page:2199-2208
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Servillo Andrea,Sacconi Riccardo,Zucchiatti Ilaria,Grachova Elena,Querques Lea,Prascina Francesco,Tombolini Beatrice,Dorin Giorgio,Mainster Martin,Bandello Francesco,Querques Giuseppe^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s40123-023-00739-4.pdf

Reference31 articles.

1. van Rijssen TJ, van Dijk EHC, Yzer S, et al. Central serous chorioretinopathy: towards an evidence-based treatment guideline. Prog Retin Eye Res. 2019;73:100770.

2. Mrejen S, Balaratnasingam C, Kaden TR, et al. Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology. 2019;126(4):576–88.

3. Wang M, Munch IC, Hasler PW, et al. Central serous chorioretinopathy. Acta Ophthalmol. 2008;86(2):126–45.

4. Gemenetzi M, De Salvo G, Lotery AJ. Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond). 2010;24(12):1743–56.

5. Spaide RF, Ledesma-Gil G, Gemmy Cheung CM. Intervortex venous anastomosis in pachychoroid-related disorders. Retina. 2021;41(5):997–1004.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regenerative Retinal Laser and Light Therapies (RELITE): Proposal of a New Nomenclature, Categorization, and Trial Reporting Standard;Lasers in Surgery and Medicine;2024-08-30

2. Laser Treatment of Central Serous Chorioretinopathy – An Update;Klinische Monatsblätter für Augenheilkunde;2024-07-24

3. Perspectives and Update on the Global Shortage of Verteporfin (Visudyne®);Ophthalmology and Therapy;2024-05-16